GlassScriptPhysician profile
Amy P Wu
NPI 1033355052
$5,149.44
in general payments reported to CMS, 2019-2025
26 companies · $740 in 2025
The $740 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $264 · 2021: $566 · 2022: $2,339 · 2023: $586 · 2024: $431 · 2025: $740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,693 · Education: $62.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,693.48 |
| Education | $62.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $911.03 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $718.41 | 2021-2025 | Dupixent |
| Acclarent, INC | $679.20 | 2019-2024 | Trudi Nav Cable |
| Optinose US, INC. | $656.71 | 2019-2025 | |
| Genzyme Corporation | $594.49 | 2020-2025 | |
| Olympus America INC. | $457.81 | 2022 | |
| Glaxosmithkline, LLC. | $212.42 | 2022-2025 | Nucala |
| Alexion Pharmaceuticals, INC. | $130.00 | 2022 | |
| Neurent Medical Limited | $124.74 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Kaleo, INC. | $111.43 | 2021-2022 | |
| Integra Lifesciences Corporation | $95.04 | 2024 | Inspira Air, Acclarent Aera, Trudi Probe |
| Alk-Abello, INC | $67.61 | 2022-2025 | Ragwitek, Odactra, Grastek |
| Blue Earth Diagnostics | $62.45 | 2023 | |
| Ars Pharmaceuticals Operations, INC. | $53.92 | 2025 | Neffy |
| Stryker Corporation | $36.46 | 2021 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $35.67 | 2022 | |
| Paratek Pharmaceuticals, INC. | $27.05 | 2025 | Xhance |
| Astrazeneca Pharmaceuticals LP | $25.94 | 2025 | Tezspire |
| Medtronic, INC. | $24.93 | 2025 | Stealthstation S8 Platform |
| Galderma Laboratories, L.P. | $23.69 | 2024 | Dysport |
| Inspire Medical Systems, INC. | $19.37 | 2023 | Inspire |
| Phadia US INC. | $18.72 | 2021 | |
| Vertical Pharmaceuticals, LLC | $18.23 | 2023 | Dsuvia |
| Aerin Medical INC. | $16.93 | 2025 | |
| Uswm, LLC | $14.00 | 2021 | |
| Intersect Ent, INC. | $13.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.